Delivery Order SPE2DB24D8002-SPE2DB25FJNCR
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,706.21, is for the delivery of ENTRESTO 97 MG-103 MG tablets in 60-count packages. The contract is a firm-fixed-price delivery order with a completion date of March 27, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,816.41 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,354.77 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product, with a completion date of September 19, 2023. Dakota Drug, Inc. is a key supplier for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support Medical's...
- This is a delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,443.39 firm fixed-price contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product. This award is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to provide a wide range of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $2,096.48 to Dakota Drug, Inc., a self-certified small disadvantaged business. This contract is for the provision of 97 mg-103 mg ENTRESTO tablets, a medication used to treat conditions such as heart failure. The delivery order was placed under Dakota Drug's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S pharmaceutical products. The contract has a firm fixed-price, with a ceiling value of $8,811.79 and a period of performance through February 24, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $10,729.29 and an ultimate completion date of May 23, 2024. Dakota Drug, Inc. is an established federal contractor, holding a significant single-award Indefinite Delivery Contract (IDC) with the...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S. The ceiling value of this contract is $2,910.31, with an ultimate completion date of October 21, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, particularly the Department of Defense. The...
- This is a federal delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $6,494.32 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 1, 2025, with a completion date of July 2, 2025. The contract is for the supply of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 60S, which is used for the treatment of cardiovascular conditions. Dakota Drug, Inc. is a key supplier of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, specifically the medication Entresto 24 mg-26 mg tablets in 60-count bottles. The contract has a total ceiling value of $2,701.93 and a completion date of July 2, 2025. The contract is a firm-fixed price delivery order, and it is not set aside for any...
- SPE2DB24D8002Indefinite Delivery Contract
- SPE2DB24D8002-SPE2DB25FJNCRDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,208.44 firm-fixed-price contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, with a focus on serving the Department of Defense through the DLA. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows it to provide a comprehensive range of medical items to support U.S. Armed Forces medical operations. This delivery order is issued under that IDC contract. The contract does not have a set-aside designation, indicating that it was competed on an unrestricted basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 2/7/25 |